Chromium supplementation improves insulin resistance in patients with type 2 diabetes mellitus [1]

Diabetic Medicine

Volumn 17, Issue 9, 2000, Pages 684-685

  Morris, B W ^a   Kouta, S ^a   Robinson, R ^a   MacNeil, S ^a   Heller, S ^a  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMIUM; CHROMIUM PICOLINATE; CORTICOSTEROID;

DIET SUPPLEMENTATION; DRUG INDUCED DISEASE; ETHICS; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LETTER; NON INSULIN DEPENDENT DIABETES MELLITUS;

ADULT; AGED; CHROMIUM; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; MIDDLE AGED;

EID: 0033786814     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2000.00342.x     Document Type: Letter

References (7)

1. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with Type 2 diabetes
2. Reversal of corticosteroid-induced diabetes mellitus with supplemental chromium
3. Enhancement in insulin sensitivity in healthy volunteers following supplementation with chromium picolinate
4. Chromium homeostasis in patients with Type II (NIDDM) diabetes
5. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
6. Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus
7. Evidence for chromium acting as an essential trace element in insulin-dependent glucose uptake in cultured mouse myotubes